Willis Towers Watson PLC

Willis Towers Watson's capital structure is characterized by a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.11, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk. In terms of profitability, the company's return on equity (ROE) is 1.51%, and its return on assets (ROA) is 0.48%, both of which are below the industry median for insurance and brokerage firms. This suggests that the company is not generating returns as efficiently as its peers. The price-to-earnings (P/E) ratio of 165.45 is significantly higher than the industry median, indicating that the stock is currently overvalued relative to its earnings. The company's revenue is not disclosed by specific segments or geographic regions, but it is known to operate globally. Given the nature of its business, it is likely that the company has a diversified geographic exposure, though the exact concentration of revenue by region is not specified. Looking at the growth trajectory, the company's revenue has remained relatively stable, with no significant year-over-year changes reported. The outlook for the current fiscal year is neutral, with no substantial growth expected. The company's capital expenditures are negative, indicating that it is not investing heavily in new assets, which could affect its long-term growth potential. The risk assessment for Willis Towers Watson indicates a medium liquidity risk and a low dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution potential is low, as the number of shares outstanding has not changed significantly between basic and diluted shares. Recent events related to the company include analyst estimates that suggest a wide range of price targets, from $275 to $409, with a mean recommendation of 2.25, indicating a generally positive outlook from analysts. The company has not disclosed any recent significant events or filings that would impact its financial position or strategic direction.